Yazar "Yolbaş, Servet" için listeleme
-
Secukinumab may be an effective treatment option for axial spondyloarthritis and psoriatic arthritis patients with a history of malignancy: multicenter real-life experience from Turkey
Ocak, Tuğba; Yağız, Burcu; Ocak, Birol; Yoğurtçu, Özge; Başıbüyük, Fatma; Tezcan, Dilek; Ermurat, Selime; İnanç, Elif; Yamancan, Gülşah; Albayrak, Fatih; Sağır, Rabia Pişkin; Bayındır Akbaş, Ayşe Nur; Cüre, Osman; Coşkun, Belkıs Nihan; Yolbaş, Servet; Karasu, Uğur; Kısacık, Bünyamin; Koca, Süleyman Serdar; Sarı, İsmail; Akar, Servet; Pehlivan, Yavuz (MDPI, 2024)Background: Secukinumab is a monoclonal antibody against interleukin 17 approved for patients with axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), and psoriasis. Treating axSpA and PsA patients with a history ...